)

Joey would have been 20 in March. But he is forever 10. 

 

   Joey was a very energetic 5th grader. He was a math whiz, enjoyed soccer, and played the violin in the county youth orchestra. He also was an artist and origamist

 

   On March 20, 2013, Joey was diagnosed with a stage 4 translocation renal cell carcinoma (tRCC). We were told there was no standard treatment for this cancer. Joey underwent two major surgeries, four different oral chemotherapies and one round of radiation. His tumors grew more and spread.

 

   In April 2014, we started a petition of compassionate use of a new immunotherapy drug called Opdivo (nivolumab) that targets the type of tumors that Joey had. It was already in trials and saving the lives of adult cancer patients, but there were no trials available for children. The petition was not granted

 

   On September 4th, another immunotherapy drug Keytruda (pembrolizumab) was approved by the FDA with adult melanoma patients.  Joey started the off-label use of Keytruda. He showed no major side effects from this drug and his tumors in his neck shrank significantly and all other tumors were stable.

 

We had so much hope. However, his tiny body was too exhausted to fight so much disease. On November 24, 2014, Joey slipped into a coma.

Joey passed away two days later.

   Joey’s journey led to the founding of a 100% volunteer-led pediatric cancer research charity, Joey’s Wings Foundation [see below for link]. Joey’s Wings has worked with the nation’s top researchers in renal cell carcinoma to discover a cure for kidney cancer and develop transforming patient care.

Joey’s Wings provides:

~free tutoring services for children battling cancer,

~offers a patient registry and tissue bank for families to connect,

~lobbies for legislation to improve treatment options, and

~provides financial assistance for pediatric kidney cancer patients.

   Joey’s love of origami inspired us to establish the Cranes for a Cure campaign, one of the foundation’s many fundraisers for pediatric cancer research and awareness. We sell colorful origami strings and mobiles consisting of paper cranes, provide them to cancer patients, and create large public art installations using the folded cranes.  By making large string mobiles, each with 2,000 cranes, these art installations would create an impactful vision and raise awareness that 2,000 children die each year from cancer.

   Joey’s Wings is incredibly grateful for all the support from the community which makes it possible for our researchers to develop less toxic therapies to treat kidney cancer among children and young adults.



Joey's Wings

Joey’s Wings Foundation, a 501c3 non-profit charity, was established in 2014 in the memory of Joey Xu, who was taken from us by childhood cancer on Nov. 26, 2014. Joey was diagnosed with xp11.2 translocation renal cell carcinoma, a rare but aggressive cancer, which has no standard treatment protocol. Our mission is to fund research that focuses on kidney cancers affecting children and young adults, raise awareness and provide support to families affected by childhood cancer.

Ten year old Joey Xu was a 5th grader at Talbot Elementary School in Gainesville, Florida. Friends and teachers described him as a funny, kind, caring, gentle, and loving boy. Joey was an intellectually gifted student. He was the award winner of the Florida Math League contest. He loved all things science and was an avid reader. Joey played the violin in the Alachua County Youth Orchestra. He was also an artist and an origamist. He loved Lego, Minecraft and soccer. Joey’s big dream was to one day play the violin in the Carnegie Hall of New York.

 

—————————
   Elevate extends heartfelt gratitude to Joey’s family for graciously sharing their talented and beloved son, Joey, even in the face of his kidney cancer diagnosis, translocation renal cell carcinoma and passing. 

 

   Joey’s experience is why Elevate is reimagining treatments for childhood cancer. Our children need us all. His experience is not isolated, but bears a painful example that so many families have now experienced.

In 2014…another immunotherapy drug Keytruda (pembrolizumab) was approved by the FDA with adult melanoma patients.  Joey started the off-label use of Keytruda. He showed no major side effects from this drug and his tumors in his neck shrank significantly and all other tumors were stable.”

It would be 2020 before Keytruda was approved by the FDA in cases of solid tumors in children with high mutational burden. [LINK Here] This is unacceptable. We must do better.

 

   As an organization Elevate seek’s to dramatically improve the lives of those diagnosed with childhood cancer. When you choose to collaborate alongside us you provide the opportunity to ‘let kids be kids‘ and change lives.

Rhabdoid Tumors: Understanding Diagnosis, Treatment, and the Impact During Kidney Cancer Awareness Month

   "On November 26th, 2023, I took Paislee to the emergency room, where she was admitted for high levels of calcium. Two days later, while changing Paislee's diaper, I felt a hard lump on the lower right side (her left side) of her abdomen and called for help."...

R01 Grants and Wilms Tumor Research: A Decade of Setbacks and Why These Critical Funding Gaps Matter

Here’s the heartbreaking reality: Wilms tumor, the most common abdominal childhood cancer & most common tumor affecting the kidneys, hasn’t received an R01 grant in over 10 years.  Every child deserves the best chance at a future, and research is how we get there....

Sharing The Experience: The Genetic Predisposition Clinic

"Ralphie’s nine-year-old sister was not identified as having a cancer predisposition syndrome until after she had been diagnosed with cancer, Wilms tumor, twice. By that time cancer filled her little body, displacing her liver, traveling throughout her abdomen,...

Ewings Sarcoma Survivor’s Mom Shares Why Blood Donations Matter

"I started donating blood when I was in high school, in a probably ill-advised scheme to work past my fear of needles." - Aimee Formo     Aimee, an incredibly well-versed and passionate childhood cancer mom and advocate currently residing in Indiana, shares with...

Call to Action in 2025

  "One of the most devastating things about this legislative mess is that some of these bills in this package had no fiscal attached, meaning they weren't going to cost taxpayers a dime!"  - Robyn Spoon, Elevate CEO & FounderHere is the site that we...

ELEVATE at the FDA

  "      "Making more drugs available to kids with cancer means solving a million small problems. Yesterday’s event provided a necessary opportunity to bring more and more of those problems to light. If we can identify the problems, name the problems, then we can...

Tatum and Maisie Moving Mountains

"The challenges of being a pediatric cancer family are innumerable. Every time you think you’ve found the worst thing, something else rears its ugly head. These past few weeks we’ve witnessed a hefty serving of that humanity, led by two young girls, Tatum Pillor and...

Outwork the Noise

Don’t listen to those voices. Let your hard work, sweat and exertion drown out the noise.  Outwork the noise. -Justin Spoon Outwork the noise means something different for each of us. Robyn Spoon, Elevate Founder shares what this meant to Justin, and what it means to...

A Son, Brother, Collegiate Runner and Asbury Graduate Diagnosed with Rhabdomyosarcoma

"Today, you don't have to do something special. You don't have to do anything amazing or overwhelming. You just gotta get of bed and do something."    - Justin Spoon - A mother's share:     Sitting in a small Lexington, Kentucky clinic room with my then 21-year-old...

Ewings Sarcoma Mom Shares

"Her diagnosis story is probably best classified as ‘trust your gut and ask for the extra tests’."    - Aimee Formo, Ewings Sarcoma Survivor's mom & Childhood Cancer AdvocateGuest Blog by: Aimee Formo    Ewings sarcoma, also abbreviated EWS,  is an aggressive type...

@2023 ELEVATE Childhood Cancer Research
and Advocacy, Inc.
is a registered 501(c)(3) non-profit organization.
EIN: 93-2185372

Join us! Stay up to date with our work and mission.

15 + 11 =

Please help keep our site secure and solve this problem.

We respect your privacy and will never sell or share your information.